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crease in KE in this group as compared with the H4M group.Hyaluronan decreases peritoneal fluid absorption: Effect of
There were no significant differences in KE, Qu, and net fluidmolecular weight and concentration of hyaluronan.
removal between the HA85K and HA280K groups and theBackground. We have recently shown that the addition of
control group.hyaluronan to peritoneal dialysis solution could decrease the
Conclusions. Our results suggest that (a) the addition ofperitoneal fluid absorption rate, possibly through decreasing
peritoneal tissue hydraulic conductivity. The physical–chemical hyaluronan to dialysate could decrease peritoneal fluid absorp-
properties of hyaluronan were found to be both molecular tion and thus increase the net ultrafiltration; this effect appears
weight and concentration dependent. In this study, we investi- to be both size dependent and concentration dependent. (b)
gated the effects of different molecular weight as well as differ- High molecular weight fraction of hyaluronan may also de-
ent concentrations of hyaluronan on the peritoneal fluid ki- crease the transcapillary Qu by decreasing tissue hydraulic con-
netics. ductivity. (c) A higher concentration of hyaluronan in dialysate
Methods. A four-hour dwell study was performed in 48 male resulted in a more marked decrease in peritoneal fluid absorp-
Sprague-Dawley rats (6 rats in each group) with 131I albumin tion (absorption to peritoneal tissues as well as direct lymphatic
(RISA) as an intraperitoneal volume marker. Each rat was intra- absorption), possibly through both decreasing tissue hydraulic
peritoneally injected with 25 ml of 1.36% glucose dialysate conductivity and increasing fluid viscosity. (d) Decreasing tis-
alone (control) or with 0.01% hyaluronan (HA) with different sue hydraulic conductivity by adding a high concentration of
molecular weights [85,000 (HA85K group), 280,000 (HA280K hyaluronan to dialysate does not decrease the transcapillary
group), 500,000 (HA500K group), and 4,000,000 (HA4M group) ultrafiltration, possibly because the osmotic effect of hyaluro-
molecular wt] or with a different concentrations of hyaluronan nan may counterbalance the decrease in transcapillary ultrafil-
[(molecular wt 500,000); 0.01% (0.01% HA group), 0.05% tration because of the decrease in tissue hydraulic conductivity.
(0.05% HA group), 0.1% (0.1% HA group), and 0.5% (0.5%
HA group) hyaluronan].
Results. The peritoneal fluid absorption rate (as assessed by
Peritoneal tissue hydraulic conductivity plays impor-the RISA elimination rate, KE) was significantly decreased in
the HA500K and H4M groups as well as in all the different tant roles in peritoneal fluid (both from blood to perito-
concentration groups (with molecular wt 500,000) as compared neal cavity and vice versa) and solute transport [1, 2].
with the control group, resulting in significantly higher net
Growing evidence suggests that the hyaluronan contentfluid removal in these groups (except for the H4M group) as
in the interstitium is the major determinant of the fluidcompared with the control group. In the 0.5% HA group (but
not in the other hyaluronan groups), the direct lymphatic ab- exchange barrier in tissues [3–8]. We have recently
sorption (KEB) was also significantly decreased. The transcapil- shown that the addition of hyaluronan (molecular weight
lary ultrafiltration rate (Qu) was significantly lower in the of approximately 500 kDa, concentration of 0.01%)HA4M group as compared with the control group but signifi-
could decrease the peritoneal fluid absorption rate, possi-cantly higher in the 0.05% HA (and tended to be higher in
bly through decreasing peritoneal tissue hydraulic con-the 0.1% HA group) as compared with the other groups. No
difference in Qu was found between the 0.5% HA group as ductivity [9]. We also demonstrated that the decreasing
compared with the control group, despite a more marked de- effect of hyaluronan on the peritoneal fluid absorption
rate was even more marked when high dialysate fill vol-
ume was used [10–13]. We speculated that the observedKey words: hydraulic conductivity, solute transport, fluid exchange,
dialysate, transport. effect of hyaluronan on peritoneal fluid absorption might
be due to the accumulation of a restrictive filter “cake”
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and biological effects of hyaluronan are, to a large extent, of the rat. Dialysate samples (0.4 ml) were taken at 0,
molecular weight and concentration dependent [15]. It 3, 15, 30, 60, 90, 120, 180, and 240 minutes after the
is not known how different molecular weights of hyaluro- dialysis fluid had been infused. Prior to each sampling,
nan and different concentrations of hyaluronan would 1 ml of the dialysate was flushed back and forth five
affect peritoneal fluid kinetics. Furthermore, the de- times through the catheter. Blood samples were drawn
crease in tissue hydraulic conductivity (which may be at 0, 120, and 240 minutes from the tail artery. After
the main reason for the decrease in peritoneal fluid ab- 240 minutes, the peritoneal cavity was opened, and the
sorption by adding hyaluronan to the dialysis fluid) may dialysate was collected using a syringe and preweighted
also possibly result in a decrease in transcapillary ultra- gauze tissue.
filtration and, therefore, may not improve the net perito- Dialysate samples (0.1 ml) and blood samples (0.1 ml
neal fluid removal, especially when high concentrations
of plasma) were analyzed for RISA activity on a Gamma
of hyaluronan are used.
Counter (Packard Instrument Company, Meriden, CT,In this study, we made a detailed investigation of the
USA) for 10 minutes each.effects of different molecular weights of hyaluronan, as
Intraperitoneal dialysate volume was estimated fromwell as different concentrations of hyaluronan on the
the dilution of RISA with corrections made for the elimi-peritoneal fluid transport characteristics.
nation of the RISA from the peritoneal cavity and sam-
ple volumes. The total peritoneal fluid absorption rate,
METHODS as assessed by the RISA elimination coefficient (KE, ml/
Forty-eight male Sprague-Dawley rats with an average min), was calculated as described previously [16]. The
body weight of 290 g (range 280 to 300 g) were divided intraperitoneal volume change (net ultrafiltration) at
into eight groups (with six rats in each group). Each rat time t was calculated as the intraperitoneal volume at
was anesthetized with a single intraperitoneal injection time t (Vt) minus the infused volume (V0). The transcapil-
of 50 mg/kg pure pentobarbital sodium (Pharmacia, Up- lary ultrafiltration rate (Qu) was defined as the rate of
psala, Sweden). The fur over the abdominal wall was intraperitoneal volume change plus the rate of fluid ab-
shaved to the skin. The animal was laid in a supine position sorption (KE) [1, 2]. The direct lymphatic absorption ofand was kept at 378C with a heating pad (CMN/Micro- fluid from peritoneal cavity was assessed as the RISA
dialysis, Stockholm, Sweden). Isotonic saline (1 ml/hr)
elimination rate from the peritoneal cavity to the bloodwas injected subcutaneously to prevent hypovolemia. A
(KEB, ml/min). KEB was calculated from the rate of in-multiholed silastic catheter (0.8 mm internal diameter;
crease of RISA amount in plasma divided by the averageVenoflon, Helsingborg, Sweden) was inserted percuta-
intraperitoneal RISA concentration [16]. The plasmaneously in the left lower quadrant of the abdomen for
volume was set at 3.6 ml/100 g body weight [15, 17]. Thedialysis fluid infusion and sampling. The experiment was
KEB values were also corrected for the RISA “spill over”started by giving an intraperitoneal injection of 25 ml of
from plasma to the body interstitium during the dwell1.36% glucose dialysate alone (control) or with 0.01%
using a constant of 0.0018 min21, as described previouslyHA with different molecular weights [85,000 (HA85K
[18, 19]. The remaining part of fluid absorption to thegroup), 280,000 (HA280K group), 500,000 (HA500K
peritoneal tissue interstitium and capillaries, KET (ml/min),group; Hyal, Toronto, Canada), and 4,000,000 (HA4M
group; Pharmacia) molecular wt] or with different con- was calculated as KE minus KEB.
centrations of hyaluronan (molecular weight 500,000) Two-way analysis of variance (ANOVA) with repeated
[0.01% (0.01% HA group, which is the same as the measurements and one-way ANOVA were applied to
HA500K group), 0.05% (0.05% HA group), 0.1% (0.1% compare intraperitoneal volume, Qu, KE, KEB, and KET.
HA group), and 0.5% (0.5% HA group) hyaluronan]. All When anova showed a significant difference among the
of the fluids were prewarmed to 378C and were mixed with groups, then Fisher’s PLSD test was used to compare
18.5 kBq 131I-human serum albumin (RISA; Isopharma the difference between different groups. The results are
AS, Kjeller, Norway). A small dose (0.2 g/liter) of human expressed as mean 6 sd. A P value of less than 0.05 was
albumin was added to the solution to minimize adhesion considered significant.
of tagged albumin to the surface of the catheter. The
solution was administered via a three-way valve (Viggo;
Connecta, Helsingborg, Sweden) and the catheter, over RESULTS
a period of approximately one minute, and allowed to
Effects of different molecular weights of hyaluronanremain in the peritoneal cavity for four hours. The intra-
on peritoneal fluid transportperitoneal hydrostatic pressure was measured after the
The intraperitoneal volume tended to be higher in allinfusion using a water manometer connected to the peri-
toneal catheter, setting the reference level at the heart of the different molecular weight hyaluronan groups,
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Fig. 1. Intraperitoneal volume versus time: Effect of different of molec-
ular weights and concentrations of hyaluronan. Symbols are: (h) control
group (N 5 6); (e) HA85K group (N 5 6); (s) HA280K group (N 5
6); (j) HA500K group (0.01% HA group; N 5 6); (>) HA4M group
(N 5 6); (n) 0.05% HA group (N 5 6); (>) 0.1% HA group (N 5 6);
(m) 0.5% HA group (N 5 6).
Fig. 2. The RISA elimination rate from the peritoneal cavity. Abbrevi-
ations are: KE, the total RISA elimination rate representing the fluid
absorption rate from the peritoneal cavity; KEB, the RISA eliminationespecially during the later part of the dwell (Fig. 1). rate to the blood from the peritoneal cavity representing the peritoneal
However, only the difference between the HA500K lymphatic absorption; KET, the RISA elimination rate to the peritoneal
tissue. Symbols are: (h) control group; ( ) HA85K group; ( ) HA280Kgroup and the control group reached statistical signifi-
group; ( ) HA500K group (0.01% HA group); ( ) HA4M group; ( )cance (P , 0.01, ANOVA repeated measurements). The
0.05% HA group; ( ) 0.1% HA group; ( ) 0.5% HA group. Significant
net ultrafiltration volume at 240 minutes was 22.26 6 differences are marked. *P , 0.05 compared with the control group;
**P , 0.01 compared with the control group (mean 6 sd).2.29, 20.64 6 1.73, 21.06 6 0.99, 20.29 6 0.30, and
20.76 6 1.18 ml for the control, HA85K, HA280K,
HA500K, and HA4M groups, respectively. The higher
intraperitoneal volume and the higher net ultrafiltration (Fig. 2). There was no significant difference in the direct
in all hyaluronan groups as compared with control group lymphatic absorption as assessed by KEB among all five
were mainly due to a lower peritoneal fluid absorption groups. Therefore, the difference in KE was mainly due
rate, KE, in the four hyaluronan groups (Fig. 2). The to the difference in the fluid absorption to peritoneal
decrease in KE was more marked in the HA4M group tissues. The transcapillary Qu between three and 240
minutes was significantly lower in the HA4M group asas compared with the other three fractions of hyaluronan
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nan as compared with the control group, and was higher
with the increase in dialysate hyaluronan concentration
(P , 0.01, ANOVA repeated measurement; Fig. 1). The
net ultrafiltration volume at 240 minutes was 22.26 6
2.29, 20.29 6 0.30, 0.49 6 2.35, 0.48 6 0.72, and 1.64 6
0.46 ml for the control, 0.01% HA, 0.05% HA, 0.1% HA,
and 0.5% HA groups, respectively. KE was significantly
lower in the 0.01% HA, 0.1% HA, and the 0.5% HA
groups as compared with the control group, especially
in the 0.5% HA group (Fig. 2). In the 0.05% HA group,
KE was only marginally lower (P 5 0.06) than in the
control group because of the larger variation in these
two groups. The direct lymphatic absorption (KEB) was
also significantly decreased in the 0.5% HA group as
compared with the other groups (Fig. 2). The Qu was
significantly higher in the 0.05% HA groups as compared
with the control, 0.01% HA, and 0.5% HA groups (all
P , 0.05) and was also significantly higher in the 0.1%
HA group as compared with the 0.5% HA group (Fig.
3). However, no significant difference in Qu was found
between the 0.01% HA, 0.1% HA, or 0.5% HA groups
and the control group. There were no significant differ-
ences in intraperitoneal hydrostatic pressure among the
five groups.
DISCUSSION
This study shows that the addition of hyaluronan to
peritoneal dialysate decreases the peritoneal fluid ab-
sorption rate. This decreasing effect may depend on both
the molecular weight of hyaluronan and the concentra-
tion of hyaluronan.
Peritoneal fluid transport in peritoneal dialysis
In the semipermeable membrane, the osmotic fluid
flow (the transcapillary Qu) is the product of the net
osmotic pressure difference across the membrane and
the membrane ultrafiltration coefficient (LPA) [16, 20].
However, peritoneal membrane is a heterogeneous
Fig. 3. Transcapillary ultrafiltration rate between 3 minutes and 240 membrane, and thus, the equation for Qu has to be modi-
minutes of the dwell. (a) P , 0.05 compared with the control and fied by taking the solute reflection coefficient (s) into
HA500K groups. (b) P , 0.05 compared with the control, 0.01% HA,
account:and 0.5% HA groups. (c) P , 0.05 compared with the 0.5% HA group.
Symbols are the same as in Figure 2.
Qu 5 LPA[(DP 2 RTRn(sDC)]
where LP is the tissue hydraulic conductivity, A is the
surface area, DP is the hydrostatic pressure gradient
compared with the control group and the HA500K group across the membrane. RTRn (sDC) is the effective os-
(both P , 0.05; Fig. 3). There were no significant differ- motic pressure exerted across the peritoneal membrane.
ences in intraperitoneal hydrostatic pressure among the It follows, therefore, that the lower the tissue hydraulic
five groups. conductivity, the lower the transcapillary Qu under the
same pressure gradient (both hydrostatic and osmotic
Effects of different concentrations of hyaluronan on gradient) and surface area.
peritoneal fluid transport It is well known that peritoneal fluid absorption occurs
The intraperitoneal volume was significantly higher in simultaneously with the peritoneal transcapillary ultra-
filtration during peritoneal dialysis [2, 21]. The fluid ab-all of the groups of different concentrations of hyaluro-
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sorption from the peritoneal cavity (as assessed by the units of N-acetylglucosamine and glucuronic acid. Hya-
luronan is found in most tissues in the body [32] and inRISA elimination rate, KE) [20, 22, 23] is due to two
the drainage dialysis fluid during peritoneal dialysis [33,separate mechanisms: (a) direct lymphatic absorption
34]. It has been shown that hyaluronan exhibits a highvia lymphatic stomata mainly in the diaphragm and, to
resistance against water flow and can thus act in tissuea lesser extent, through visceral lymphatic pathway; and
as a barrier against rapid changes in water content [35].(b) fluid absorption into the peritoneal tissue intersti-
In the interstitium, hyaluronan decreases the water per-tium, where the fluid is absorbed into the capillary due
meability of the membrane [10, 30]. One recent studyto the Starling forces, whereas the macromolecules are
suggests that hyaluronan is a determinant of the fluidabsorbed slowly into local lymphatics together with a
exchange barrier of the endothelium [30, 31].fraction of the fluid [24].
In agreement with our previous studies, this studyDirect lymphatic absorption can be assessed as the
showed that the peritoneal fluid absorption rate couldrate of appearance of intraperitoneally administered
be decreased by adding hyaluronan to the peritonealmacromolecules (that is, RISA) in the blood, KEB [25,
dialysis fluid. Our results also show that high molecular26]. It is generally believed that the direct lymphatic
weight hyaluronan (molecular wt 4,000,000) could de-absorption is mainly via specialized end lymphatic open-
crease the fluid absorption more markedly, but at theings (stomata) located in the subdiaphragmatic perito-
same time, it decreases the transcapillary ultrafiltration.neum [27–29]. It has been shown that KEB is rather inde-
The postulated effect of molecular weight of hyaluronanpendent on the intraperitoneal hydrostatic pressure
on the resistance of peritoneal fluid flow is presented[3–5]. Diaphragmatic movements during respiration that
schematically in Figure 4. The difference in behaviorresult in lymph propulsion have been postulated to facili-
between lower molecular weight fractions and highertate lymphatic drainage [6] and should presumably not
molecular weight fractions may be induced by a differ-be affected by tissue hydraulic conductivity. On the other
ence in the entanglement of the hyaluronan molecularhand, we (also in this study) and others have demon-
chains [12]. It has been reported that hyaluronan mole-strated that the KEB only accounts for 10% to 30% of
cules behave in solution as highly hydrated randomlythe total fluid absorbed from the peritoneal cavity [30,
kinked coils, which start to entangle at concentrations31]. The major part of the fluid losses from the peritoneal
of less than 1 mg/ml [30, 31]. It was found that for induc-cavity is evidently caused by net fluid entry into the
ing the entanglement of molecular chains of hyaluronan,tissues surrounding the peritoneal cavity (KET), repre-
increasing the molecular weight of hyaluronan was moresenting an intermediate compartment between the peri-
effective than increasing the concentration of the lowertoneal cavity and plasma. Flessner and Schwab have
molecular weight fractions [12]. The entangled networkdemonstrated that the movement of the protein marker
will form a firm structure that therefore has a better(along with fluid; this bulk flow may be denoted perito-
resistance to fluid flow across this layer [10]. Althoughneal fluid absorption) from the cavity that occurs into
the concentration (0.01%) of different molecular weightadjacent tissues is in accordance with Darcy’s Law [24]:
fractions of hyaluronan in the dialysate we used in this
study was lower than the reported coil overlap concen-
n 5
K
m
dptissue
dx tration (more than 0.05%) [31], the size of the hydrated
hyaluronan would prevent it from reaching the intersti-
where n 5 fluid velocity in tissue (equal to KET/A), K 5 tium of the peritoneum during the dwell. As peritoneal
tissue hydraulic conductivity, m 5 fluid viscosity, and fluid absorption (bulk flow) is driven mainly by intraperi-
dPtissue/dx 5 the tissue hydrostatic pressure gradient [10]. toneal hydrostatic pressure and exists during the whole
Therefore, one can expect that (a) the lower the tissue dwell [24], a layer of sieved hyaluronan molecules (filter
hydraulic conductivity the lower the peritoneal fluid ab- “cake”) may thus build up at the peritoneal cavity–
sorption to peritoneal tissues, and (b) the higher the membrane interface [14], similar to what has been dem-
fluid viscosity in the peritoneal cavity the lower the fluid onstrated in joint [36]. The hyaluronan concentration
absorption rate. within this filter “cake” should conceivably be much
higher than the concentration in the dialysate. Further-
Effects of hyaluronan on peritoneal fluid transport more, Scott et al, by using rotary shadowing-electron
It is obvious, therefore, that tissue hydraulic conduc- microscopy and computer simulation, found that hyalur-
tivity plays an important role not only in peritoneal trans- onan is fundamentally a network-forming polymer, with
capillary ultrafiltration, but also in peritoneal fluid ab- marked capacity to form branch points with other mole-
sorption. Extracellular matrix hyaluronan content has cules, relinking at other points to form three-dimensional
been shown to be the major determinant of tissue hy- honeycomb-like structures of enormous dimensions, even
draulic conductivity [24]. Hyaluronan is a long polysac- at very low (less than 1 mg/ml) concentrations [32]. In
addition, adding high molecular weight hyaluronan exog-charide chain that is made up of repeating disaccharide
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Fig. 4. Schematic description of the effect of
different molecular weights and different con-
centrations of hyaluronan (in the peritoneal
membrane or within the filter “cake”) on the
peritoneal fluid absorption. Abbreviations
are: Ci, the concentration of hyaluronan; Mi,
the molecular weight of hyaluronan. (Modi-
fied from Berriaud et al [11].)
enously may stabilize the endogenous hyaluronan (as it in these groups. This may be due to the fact that hyaluro-
may form bridges between endogenous chains) [37], nan is not an ideal osmotic agent [3]. Hyaluronan affects
which forms a stagnant layer at the mesothelial cell sur- transcapillary ultrafiltration not only through decreasing
face [35]. Higher molecular weight fractions of hyaluro- the tissue hydraulic permeability (which tends to decrease
nan may also have a better effect on stabilizing the en- transcapillary ultrafiltration), but also through increasing
dogenous hyaluronan layer. the osmotic pressure of the dialysate (which tends to
On the other hand, our results show that increasing increase the transcapillary ultrafiltration). The osmotic
the concentration of a lower molecular weight fraction pressure of hyaluronan is strongly concentration depen-
of hyaluronan could also significantly decrease the peri- dent [30, 31]. It increases exponentially rather than lin-
toneal fluid absorption, both the absorption to peritoneal early with increasing concentration of hyaluronan. There-
tissues and the direct lymphatic absorption. This may be fore, the osmotic effect counterbalanced off the decrease
due to the fact that the increase in dialysate hyaluronan in tissue hydraulic conductivity (induced by hyaluronan),
concentration may both increase the accumulation of which otherwise could have led to a decrease in the trans-
hyaluronan in the filter “cake” (increased entanglement capillary ultrafiltration. The difference in transcapillary
to some extent) and increase the fluid viscosity. By sedi- Qu between the 0.05% HA group and the 0.5% HA
mentation analysis, it was shown that the hydraulic con- group may be due to the balance of two different effects
ductivity decreases a thousandfold when the hyaluronan of hyaluronan on peritoneal transport: (a) the decreasing
concentration increases from 0.01% to 1% [38]. It was effect on tissue hydraulic conductivity and (b) the os-
also found that the viscosity of the hyaluronan solution motic effect of hyaluronan.
increased sharply at concentrations above the entangle- In summary, our results suggest that (1) the addition of
ment point (0.1%) [10, 30]. As schematically shown in
hyaluronan to dialysate could decrease peritoneal fluid
Figure 4, by increasing the hyaluronan concentration
absorption (which may be due to its impact on tissueof lower molecular weight fractions, an increase in the
hydraulic permeability and fluid viscosity) and thus in-internal friction and thus an increase in viscosity are
crease the net ultrafiltration; this effect appears to beobtained. According to Darcy’s Law, if the dialysate has
both size dependent and concentration dependent. (2)a higher fluid viscosity, a lower fluid absorption may be
The high molecular weight fraction of hyaluronan mayexpected. It is thus not surprising that both peritoneal
also decrease the transcapillary ultrafiltration by decreas-fluid absorption to peritoneal tissues and the direct peri-
ing tissue hydraulic conductivity. (3) A higher concentra-toneal lymphatic absorption were retarded by the highest
tion of hyaluronan in dialysate resulted in a more markeddialysate hyaluronan concentration (0.5%) in this study.
decrease in peritoneal fluid absorption (absorption toIt is interesting, however, to note that the significant
peritoneal tissues as well as direct lymphatic absorption),decrease in fluid absorption rate with the hyaluronan
possibly through both decreasing tissue hydraulic con-concentration of 0.5% (even more marked than in the
ductivity and increasing fluid viscosity. (4) DecreasingHA4M group; Fig. 2) was not associated with a significant
tissue hydraulic conductivity by adding a high concentra-decrease in the transcapillary Qu (compared with the con-
tion of hyaluronan to dialysate does not decrease thetrol group), as was the case in the high molecular weight
transcapillary ultrafiltration, possibly because the os-fraction group (the HA4M group; Fig. 3). Furthermore,
motic effect of hyaluronan may counterbalance the de-the transcapillary Qu was even higher in the 0.05% HA
crease in transcapillary ultrafiltration due to the decreaseand 0.1% HA groups as compared with the control
group, despite a lower peritoneal fluid absorption rate in tissue hydraulic conductivity.
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